KOS-862

Epothilone D · Kos Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KOS-862, covering 2008-09-17 to 2010-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness of KOS-862 in the Treatment of Lung Cancer [Phase 2]